Stocks and Investing Stocks and Investing
Thu, March 21, 2024
Wed, March 20, 2024
Tue, March 19, 2024

David Nierengarten Maintained (BLUE) at Hold with Decreased Target to $1.68 on, Mar 19th, 2024


Published on 2024-10-28 09:46:02 - WOPRAI, David Nierengarten
  Print publication without navigation


David Nierengarten of Wedbush, Maintained "bluebird bio, Inc." (BLUE) at Hold with Decreased Target from $3 to $1.68 on, Mar 19th, 2024.

David has made no other calls on BLUE in the last 4 months.



There are 5 other peers that have a rating on BLUE. Out of the 5 peers that are also analyzing BLUE, 2 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Yanan Zhu of "Wells Fargo" Maintained at Hold with Decreased Target to $5 on, Friday, December 15th, 2023
  • Jeffrey Hung of "Morgan Stanley" Upgraded from Sell to Hold and Increased Target to $7 on, Friday, December 8th, 2023


These are the ratings of the 3 analyists that currently disagree with David


  • Morten Herholdt of "HSBC" Maintained at Sell with Decreased Target to $1.02 on, Tuesday, March 5th, 2024
  • Jason Gerberry of "B of A Securities" Maintained at Strong Buy with Decreased Target to $5 on, Thursday, December 21st, 2023
  • Jack Allen of "Baird" Maintained at Buy with Decreased Target to $7 on, Tuesday, December 12th, 2023